You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Solid Tumor

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Philadelphia (Nivolumab, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 6, 2022

Hepatocellular Carcinoma Trial in Chongqing (Laparoscopic Anatomical Hepatectomy, Laparoscopic Aon-anatomical Hepatectomy)

Recruiting
  • Hepatocellular Carcinoma
  • Laparoscopic Anatomical Hepatectomy
  • Laparoscopic Aon-anatomical Hepatectomy
  • Chongqing, Chongqing, China
    Southwest Hospital
Feb 10, 2022

Rectal Cancer Trial in Taipei (Surgery)

Recruiting
  • Rectal Cancer
  • Surgery
  • Taipei, Taiwan
    Jin-Tung LIANG
Jul 27, 2023

Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

Recruiting
  • Non-Hodgkins Lymphoma
  • Charlotte, North Carolina
  • +21 more
Jan 18, 2023

Squamous Cell Lung Cancer Trial in United States (ZEN003694)

Recruiting
  • Squamous Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Nov 1, 2022

Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab Trial in Shanghai (Tislelizumab plus chemo)

Recruiting
  • Cancer of Unknown Primary
  • +5 more
  • Tislelizumab plus chemotherapy
  • Shanghai, Shanghai, China
    ChangZheng Hospital
Feb 6, 2022

Metastatic Melanoma Trial in Los Angeles (sunitinib malate, temozolomide)

Completed
  • Metastatic Melanoma
  • Los Angeles, California
    University of California Los Angeles (UCLA)
Jul 30, 2020

Hepatocellular Carcinoma Trial in China (Anlotinib HCl capsules, Penpulimab injection, Anlotinib HCl capsules -matching ,

Recruiting
  • Hepatocellular Carcinoma
  • Anlotinib hydrochloride capsules, Penpulimab injection
  • Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo
  • Bengbu, Anhui, China
  • +66 more
May 15, 2023

Advanced Solid Tumors, HER2-positive Breast Cancer Trial in Beijing (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041 200mg

Recruiting
  • Advanced Solid Tumors
  • HER2-positive Breast Cancer
  • ZN-A-1041 50mg BID
  • +9 more
  • Beijing, Beijing, China
    Cancer hospital Chinese academy of medical sciences
Oct 19, 2020

Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With

Recruiting
  • Tumor Cell, Circulating
  • Adjuvant radiotherapy
  • neoadjuvant and adjuvant chemotherapy
  • Jena, Germany
    Department of Radiooncology, Jena
Sep 28, 2021

Prostate Cancer Trial in France (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • Angers, France
  • +37 more
Jan 17, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Experimental Observation
  • +3 more
  • Baltimore, Maryland
  • +5 more
Oct 16, 2023

Sarcopenia and Nutritional Status in Early-stage Non-small Cell

Not yet recruiting
  • Sarcopenia
  • +2 more
  • Inbody 570
  • +2 more
  • Shanghai, Shanghai, China
    Huadong hospital, Fudan University
Jan 27, 2022

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • San Diego, California
    Persephone Biosciences, Inc.
Feb 19, 2021

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Nausea, Vomiting, Pain Trial in Freiburg (Palonosetron Hydrochloride, Placebo)

Not yet recruiting
  • Nausea
  • +3 more
  • Palonosetron Hydrochloride
  • Placebo
  • Freiburg, Germany
    Clinic for Palliative Care, Medical Center, University of Freibu
Mar 29, 2022

Prostate Cancer Trial in Beijing (68Ga-PSMA-617, 68Ga-P16-093)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 4, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Bone Metastases From Solid Tumors Trial in Guangzhou (LY01011, Xgeva®)

Recruiting
  • Bone Metastases From Solid Tumors
  • Guangzhou, China
    The First Affiliated Hospital of Guangdong Pharmaceutical Univer
Jun 2, 2021

Circulating Tumor DNA in Locally Advanced Head and Neck Squamous

Suspended
  • Head and Neck Neoplasm
  • Carcinoma, Squamous Cell
  • Blood and tumor samples
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Feb 24, 2022

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

Breast Cancer Trial in Spain (Atezolizumab + Trastuzumab + Vinorelbine)

Recruiting
  • Breast Cancer
  • Atezolizumab + Trastuzumab + Vinorelbine
  • Granada, Andalucía, Spain
  • +14 more
Mar 2, 2022

Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Preoperative Radiotherapy for Non-responder Patients After

Completed
  • Breast Neoplasms
  • +3 more
  • Radiotherapy
  • Istanbul, Turkey
    Istanbul Breast Society
Mar 1, 2022

Kaposi Sarcoma Trial in Beverly Hills, Sarasota, Dallas (sEphB4-HSA)

Recruiting
  • Kaposi Sarcoma
  • Beverly Hills, California
  • +2 more
Oct 4, 2021